The PTB7-Th/PC ₇₁ BM-based PSCs exhibit a significantly improved PCE of 8.33% and device stability for the halogen-free solid ROPD additive.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: